Pneumo News

, Volume 9, Issue 7, pp 30–34 | Cite as

Nicht nur Infektionskrankheiten

Lungenerkrankungen bei HIV-Infektion

fortbildung
First Online:
  • 16 Downloads

Die antiretrovirale Therapie hat das Langzeitüberleben von HIV-Infizierten enorm verbessert. Opportunistische Infektionen sind dadurch seltener geworden, COPD, Asthma und die seltenen Lungenfibrosen dagegen relativ häufiger. Trotzdem sind HIV-Kranke mit schlechtem Immunstatus besonders durch pulmonale Infektionen gefährdet.

This is a preview of subscription content, log in to check access.

Literatur

  1. 1.
    Gueler A, Moser A, Calmy A et al. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS Lond Engl. 2017;31(3):427–436Google Scholar
  2. 2.
    Pupaibool J, Limper AH. Other HIV-associated pneumonias. Clin Chest Med. 2013;34(2):243–254CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Collini P, Morris A. Maintaining lung health with longstanding HIV. Curr Opin Infect Dis. 2016;29(1):31–38CrossRefPubMedGoogle Scholar
  4. 4.
    Staitieh B, Guidot DM. Noninfectious pulmonary complications of human immunodeficiency virus infection. Am J Med Sci. 2014;348(6):502–511CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lange C, Schaaf B, Dalhoff K. [HIV and lung]. Pneumol Stuttg Ger. 2004;58(6):416–427CrossRefGoogle Scholar
  6. 6.
    Feldman C, Anderson R. HIV-associated bacterial pneumonia. Clin Chest Med. 2013;34(2):205–216CrossRefPubMedGoogle Scholar
  7. 7.
    Crothers K, Huang L, Goulet JL et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183(3):388–395CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Gingo MR, Morris A, Crothers K. Human immunodeficiency virus-associated obstructive lung diseases. Clin Chest Med. 2013;34(2):273–282CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Drummond MB, Kirk GD. HIV-associated obstructive lung diseases: insights and implications for the clinician. Lancet Respir Med. 2014;2(7):583–592CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kirk GD, Merlo C, O’ Driscoll P et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(1):103–110. doi:10.1086/518606.CrossRefGoogle Scholar
  11. 11.
    Sigel K, Crothers K, Dubrow R et al. Prognosis in HIV-infected patients with non-small cell lung cancer. Br J Cancer. 2013;109(7):1974–1980CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Hoffmann C, Kohrs F, Sabranski M et al. HIV-associated lung cancer: survival in an unselected cohort. Scand J Infect Dis. 2013;45(10):766–772CrossRefPubMedGoogle Scholar
  13. 13.
    Dalhoff K, Marxsen J, Steinhoff J. [Pneumonias and immunosuppression]. Internist. 2007;48(5):507–508, 510-518CrossRefPubMedGoogle Scholar
  14. 14.
    Unnewehr M, Friederichs H, Bartsch P Schaaf B. High Diagnostic Value of a New Real-Time Pneumocystis PCR from Bronchoalveolar Lavage in a Real-Life Clinical Setting. Respir Int Rev Thorac Dis. 2016;92(3):144–149Google Scholar
  15. 15.
    Huang L, Crothers K. HIV-associated opportunistic pneumonias. Respirol Carlton Vic. 2009;14(4):474–485CrossRefGoogle Scholar
  16. 16.
    Rockstroh J, Hoffmann C. HIV 206/2017. Hamburg: Medizin Fokus Verlag; 2016. www.hivbuch.de
  17. 17.
    Thoden J, Potthoff A, Bogner JR et al. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection. 2013;41 Suppl 2:S91–115CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin 2017

Authors and Affiliations

  1. 1.Medizinische Klinik Nord - Pneumologie / Infektiologie / IntensivmedizinKlinikum Dortmund gGmbHDortmundDeutschland

Personalised recommendations